7th Annual Symposium on Current Strategies in the Treatment of Hodgkins Lymphoma, B-cell Lymphoma, Multiple Myeloma and Leukemia

This series of 3 webcasts is intended to improve care of patients with hematological malignancies such as Hodgkins lymphoma, B-cell lymphoma, multiple myeloma and leukemia by accelerating adoption of new guidelines and evidence-based practice change. In-depth discussion of novel agents at various stages of clinical development will be given significant focus. Participants will also gain clinical decision-making strategies for integration of novel therapeutic options. 

Each activity offers:

1.50-2.00 AMA PRA Category 1 Credit(s)TM
1.50-2.00 CE for Nurses
1.50-2.00 CE for Pharmacists (0.20 CEUs)

FACULTY

Jorge Cortes, MD
Professor and Chair
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson
  Cancer Center
Houston, TX

Nitin Jain, MD
Assistant Professor
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson
  Cancer Center
Houston, TX

Elisabet E. Manasanch, MD
Assistant Professor
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson
  Cancer Center
Houston, TX

Robert Orlowski, MD, PhD
Professor of Medicine
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson
  Cancer Center
Houston, TX

Farhad Ravandi, MD
Professor of Medicine
Department of Leukemia
Division of Cancer Medicine
The University of Texas MD Anderson
  Cancer Center
Houston, TX

Jorge E. Romaguera, MD
Professor of Medicine
Department of Lymphoma/Myeloma
University of Texas M. D. Anderson
  Cancer Center
Houston, TX

William G. Wierda, MD
Professor of Medicine
Department of Lymphoma/Myeloma
Division of Cancer Medicine
University of Texas MD Anderson
  Cancer Center
Houston, TX

Jointly provided by



These activities are supported by educational grants from
Amgen, Inc, Takeda Oncology, Bayer HealthCare Pharmaceuticals Inc., Celgene Corporation, and Novartis Pharmaceuticals Corporation